title: Measurement of radial bone mineral density in patients after heart transplantation.
abstract: Limited physical activity, steroidotherapy and immunosuppression are known risk factors for the development of osteoporosis. The purpose of our current work was to investigate whether patients after heart transplantation (Htx) have an increased incidence of osteoporosis. We compared bone mineral density (BMD) in 32 post-transplant patients with a reference group of 1548 healthy age-matched males. Measurement of BMD was carried out with a Dtx 100 Osteometer on the distal and ultradistal segment of the non-dominant radius. Our results revealed a decreased BMD in HTx patients ranging from 6.9 to 10% in the ultradistal (p = 0.0446) and from 0.4 to 3.5% in the distal segment (p = 0.0593).
authors.affiliation: Cardiac and Vascular Surgery Department, Collegium Medicum, Jagiellonian University, Kraków, Poland.
authors.forename: A M
authors.initials: AM
authors.lastname: Garlicki
authors.forename: F
authors.initials: F
authors.lastname: Orchowski
authors.forename: T
authors.initials: T
authors.lastname: Myrdko
authors.forename: S
authors.initials: S
authors.lastname: Wójcik
authors.forename: E
authors.initials: E
authors.lastname: Czerwiński
authors.forename: R
authors.initials: R
authors.lastname: Kukiełka
authors.forename: B
authors.initials: B
authors.lastname: Kapelak
authors.forename: A
authors.initials: A
authors.lastname: Dziatkowiak
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D015519:Bone Density; D001851:Bone Diseases, Metabolic / Q000453:epidemiology / Q000209:etiology; D002648:Child; D005500:Follow-Up Studies; D016027:Heart Transplantation / Q000502:physiology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D015994:Incidence; D008297:Male; D008875:Middle Aged; D010024:Osteoporosis / Q000453:epidemiology / Q000209:etiology; D005082:Physical Exertion; D011183:Postoperative Complications / Q000453:epidemiology; D011884:Radius; D012016:Reference Values; D013256:Steroids / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D007166:Immunosuppressive Agents; D013256:Steroids